TITLE

Sinovac gets GMP Certificate for Flu/Hepatitis A

PUB. DATE
September 2011
SOURCE
Worldwide Biotech;Sep2011, Vol. 23 Issue 9, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that China-based biopharmaceutical maker Sinovac Biotech Ltd. has received a good manufacturing practice (GMP) certification from the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) of Mexico Ministry of Health for its flu/hepatitis A vaccine. The agency has issued the certificate after its visit of Sinovac's facility in September 2010. The certificate will expire on January 12, 2014.
ACCESSION #
65177060

 

Related Articles

  • VACCINE REPORT.  // BioPharm International;May2008, Vol. 21 Issue 5, p12 

    The article offers news briefs related to vaccines. Sinovac Biotech Ltd. has announced that Panflu, its pandemic influenza H5N1 whole viron inactivated vaccine, has been granted a production license by the China State Food and Drug Administration. The U.S. Food and Drug Administration announced...

  • Sinovac Biotech wins Mexican approval for pandemic influenza vaccine.  // PharmaWatch: Biotechnology;Dec2009, Vol. 8 Issue 12, p15 

    The article reports that vaccine provider Sinovac Biotech Co. Ltd. has received a certificate of approval from the Secretaria de Salud to distribute its H1N1 pandemic influenza vaccine in Mexico. It states that the drug is the first Chinese-developed H1N1 vaccine to be registered in the country....

  • Biotechnology News Round-Up.  // PharmaWatch: Monthly Review;Dec2009, Vol. 8 Issue 12, p32 

    The article offers information on biotechnology companies. Sinovac Biotech Ltd. has received approval to distribute Panflu.1, its H1N1 pandemic influenza vaccine, in Mexico. Morphotek Inc. signs a licensing agreement with Centocor Ortho Biotech Inc. for the development and commercialization of...

  • Dow Corning Ramps up Pharmaceutical Grade Silicone Tubing Production in Response to Influenza Outbreak.  // China Chemical Reporter;11/6/2009, Vol. 20 Issue 31, p12 

    The article reports on the increase production of pharmaceutical grade silicone tubing by Dow Corning Corp. to meet the demand of pharmaceutical customers developing flu vaccines. The company will produce additional tubing products designed for critical fluid transport and filling applications...

  • CLINIC ROUNDUP.  // BioWorld Today;5/10/2007, Vol. 18 Issue 91, p9 

    The article offers news briefs on the biotechnology industry. Florida-based Catalyst Pharmaceutical Partners Inc. reported that its CPP-109 (Vigabatrin tablets) is bioavailable and bioequivalent to Sabril tablets marketed in Europe by Sanofi Aventis. California-based Cell Genesys Inc. started...

  • Sinovac: Panflu on track in pandemic flu.  // PharmaWatch: Biotechnology;May2006, Vol. 5 Issue 5, p5 

    The article reports on the completion of the immunization schedule in the phase I pandemic influenza vaccine trial of Sinovac Biotech Co. Ltd. in 2006. The company has announced that all 120 volunteers in a phase I clinical trial of its avian influenza vaccine Panflu have completed the two-shot...

  • Sinovac Launched New Vaccine Base.  // China Chemical Reporter;3/21/2010, Vol. 21 Issue 6, p19 

    The article reports on the ceremony conducted by the Sinovac Biotech Ltd. for the construction on a new vaccine base at Changping district, Beijing in China on March 3, 2010.

  • SINOVAC DEVELOPING VACCINE FOR HAND, FOOT, AND MOUTH DISEASE.  // Worldwide Biotech;Nov2008, Vol. 20 Issue 11, p2 

    The article reports that Chinese vaccines developer Sinovac Biotech Ltd. has initiated the development of a vaccine human enterovirus 71 (EV 71), which causes hand, foot, and mouth disease (HFMD). Sinovac will be supplied with epidemiology study results from the outbreak area to facilitate its...

  • Financings Roundup.  // BioWorld Today;2/2/2010, Vol. 21 Issue 21, p5 

    The article reports that the underwriters of the public share offering of Sinovac Biotech Ltd. exercised in full their option to purchase an additional 1.5 million common shares to cover overallotments.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics